Cargando…

Single fraction high-dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: toxicities and early outcomes from a single institutional experience

PURPOSE: High-dose-rate brachytherapy (HDR-BT) delivered in a single fraction as monotherapy is a potential treatment modality for low- and intermediate-risk prostate cancer (LIR-PC); however, outcome data with this technique remain limited. Here we describe our institutional HDR monotherapy experie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barnes, Justin M., Gabani, Prashant, Sanders, Max, Chundury, Anupama, Altman, Michael, Garcia-Ramirez, Jose, Li, Harold, Zoberi, Jacqueline E., Baumann, Brian C., Gay, Hiram A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854868/ https://www.ncbi.nlm.nih.gov/pubmed/31749847 http://dx.doi.org/10.5114/jcb.2019.89367

Ejemplares similares

Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysis
por: Roy, Amit, et al.
Publicado: (2021)

Treatment patterns of high-dose-rate and low-dose-rate brachytherapy as monotherapy for prostate cancer
por: Barnes, Justin, et al.
Publicado: (2019)

High-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer: long-term experience of Swedish single-center
por: Johansson, Bengt, et al.
Publicado: (2021)

Single-fraction low-energy electronic brachytherapy for conjunctival lymphoma
por: Sarria, Gustavo R., et al.
Publicado: (2020)

Clinical outcomes and patterns of care in the treatment of carcinosarcoma of the breast
por: Kennedy, William R., et al.
Publicado: (2019)

High-dose-rate brachytherapy delivered in two fractions as monotherapy for low-risk prostate cancer
por: Cendales, Ricardo, et al.
Publicado: (2015)

Single-Fraction Adjuvant Electronic Brachytherapy after Resection of Conjunctival Carcinoma
por: Sarria, Gustavo R., et al.
Publicado: (2021)

Single-fraction image-guided high-dose-rate brachytherapy for head and neck cancer: three cases of palliative brachytherapy
por: Ota, Yoshiaki, et al.
Publicado: (2020)

Ruthenium brachytherapy for uveal melanoma – single institution experience
por: Rospond-Kubiak, Iwona, et al.
Publicado: (2017)

High-dose-rate fractionated brachytherapy monotherapy for localized prostate cancer: a systematic review and meta-analysis
por: Anderson, Eric M., et al.
Publicado: (2021)

A radiobiological study of the schemes with a low number of fractions in high-dose-rate brachytherapy as monotherapy for prostate cancer
por: Guirado, Damián, et al.
Publicado: (2020)

Two-fraction high-dose-rate brachytherapy within a single day combined with external beam radiotherapy for prostate cancer: single institution experience and outcomes
por: Liu, Junyang, et al.
Publicado: (2016)

Clinical Outcomes of MRI-Guided Adaptive Brachytherapy for Each Fraction in Locally Advanced Cervical Cancer: A Single Institution Experience
por: Chi, Yunbo, et al.
Publicado: (2022)

A Brief Review of Low-Dose Rate (LDR) and High-Dose Rate (HDR) Brachytherapy Boost for High-Risk Prostate
por: Fischer-Valuck, Benjamin W., et al.
Publicado: (2019)

Logistical, technical, and radiation safety aspects of establishing a radiopharmaceutical therapy program: A case in Lutetium‐177 prostate‐specific membrane antigen (PSMA) therapy
por: Zoberi, Jacqueline E., et al.
Publicado: (2023)

Clinical implementation of multisequence MRI‐based adaptive intracavitary brachytherapy for cervix cancer
por: Zoberi, Jacqueline E., et al.
Publicado: (2016)

High-dose-rate brachytherapy as monotherapy for localized prostate cancer using three different doses – 14 years of single-centre experience
por: Soatti, Carlo Pietro, et al.
Publicado: (2020)

Single fraction of HDR brachytherapy for prostate cancer: Results of the SiFEPI phase II prospective trial
por: Hannoun-Levi, Jean-Michel, et al.
Publicado: (2022)

High-Dose-Rate Brachytherapy as Monotherapy for Low- and Intermediate-Risk Prostate Cancer. Oncological Outcomes After a Median 15-Year Follow-Up
por: Behmueller, Manuel, et al.
Publicado: (2021)

Prostate brachytherapy with iodine-125 seeds: analysis of a single institutional cohort
por: Leite, Elton Trigo Teixeira, et al.
Publicado: (2019)

Radiation-Induced Brachial Plexopathy in Patients With Breast Cancer Treated With Comprehensive Adjuvant Radiation Therapy
por: Rudra, Soumon, et al.
Publicado: (2020)

Single fraction multimodal image guided focal salvage high-dose-rate brachytherapy for recurrent prostate cancer
por: Zamboglou, Constantinos, et al.
Publicado: (2016)

Single-fraction high-dose-rate brachytherapy: a scoping review on outcomes and toxicities for all disease sites
por: Kazemi, Mehdi, et al.
Publicado: (2022)

Feasibility of MRI targeted single fraction HDR brachytherapy for localized prostate carcinoma: ProFocAL-study
por: Hass, Peter, et al.
Publicado: (2022)

The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer
por: Yoshioka, Yasuo, et al.
Publicado: (2013)

High-dose-rate brachytherapy as monotherapy for prostate cancer: technique, rationale and perspective
por: Yoshioka, Yasuo, et al.
Publicado: (2014)

Quality of life after high-dose-rate brachytherapy monotherapy for prostate cancer
por: Contreras, Jessika A., et al.
Publicado: (2015)

Induction chemotherapy in the treatment of nasopharyngeal carcinoma: Clinical outcomes and patterns of care
por: Gabani, Prashant, et al.
Publicado: (2018)

In vivo assessment of catheter positioning accuracy and prolonged irradiation time on liver tolerance dose after single-fraction (192)Ir high-dose-rate brachytherapy
por: Lüdemann, Lutz, et al.
Publicado: (2011)

Efficacy and safety of image-guided interstitial single fraction high-dose-rate brachytherapy in the management of metastatic malignant melanoma
por: Bretschneider, Tina, et al.
Publicado: (2015)

Accelerated partial breast irradiation in a single 18 Gy fraction with high-dose-rate brachytherapy: preliminary results
por: Latorre, Javier Anchuelo, et al.
Publicado: (2018)

Improve definition of titanium tandems in MR-guided high dose rate brachytherapy for cervical cancer using proton density weighted MRI
por: Hu, Yanle, et al.
Publicado: (2013)

Salvage brachytherapy for locally recurrent prostate cancer after single-fraction 19 Gy high-dose-rate brachytherapy: toxicity, prostate-specific antigen kinetics, and cancer control
por: Mayrata, Esther, et al.
Publicado: (2021)

Funtional significance of the intermediate lesion in a single coronary artery assessed by fractional flow reserve
por: Ha, Sang Jin, et al.
Publicado: (2014)

Low-/high-dose-rate brachytherapy boost in patients with intermediate-risk prostate cancer treated with radiotherapy: long-term results from a single institution team experience
por: Villalba, Silvia Rodríguez, et al.
Publicado: (2021)

Clinical outcomes and toxicity of proton beam radiation therapy for re-irradiation of locally recurrent breast cancer
por: Gabani, Prashant, et al.
Publicado: (2019)

A Comparison of Single Fraction and Multi Fraction Radiosurgery on the Gamma Knife ICON: A Single Institution Review
por: Loftus, Joseph P., et al.
Publicado: (2022)

Intensity modulated radiation therapy and surgery for Management of Retroperitoneal Sarcomas: a single-institution experience
por: Cosper, Pippa F., et al.
Publicado: (2017)

High-dose-rate brachytherapy for soft tissue sarcoma in children: a single institution experience
por: Viani, Gustavo A, et al.
Publicado: (2008)

Iodine-125 seed brachytherapy for early stage prostate cancer: a single-institution review
por: Zuber, Simon, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2vg60tg3trh6tap79v7m69bieh